Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Selfcare, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Acquires diabetes care product supplier Can-Am Care for approximately $27 mil., including $13.6 mil. in cash, a $2 mil. note and about 1.1 mil. shares of Selfcare common stock. Can-Am, which markets insulin syringes, blood lancets, glucose tablets and specialty skin creams to pharmacies nationwide, generated approximately $25 mil. in revenues in fiscal 1997. Selfcare, which makes health maintenance and home self-test diagnostic products for the diabetes, women's health and nutritional supplement markets, calls the acquisition "an excellent fit with the rest of Selfcare's business" and anticipates "good opportunities to increase our total shelf space in pharmacies where our products are sold." The acquisition is expected to be accretive to earnings...

You may also be interested in...

Wockhardt Preps To Deliver 100 M Doses Of AZ Vaccine

As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies

ECHA Deliberates On Final Microplastic Proposal As Beauty Industry’s Fate Hangs In Balance

A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.

QUOTED. 2 December. Laurent Faracci.

Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts